New Talisman Gold Mines (NTL) / FY26
PBT swung to a $2.2m loss as FY25's impairment reversal dropped out
Operating cash outflow widened to NZ$2.0m, showing a cash-hungry gold explorer behind a distorted profit swing.
2 July 2026
Insights
The latest Annolyse result briefings in one feed, with the main analytical takeaway surfaced before the click.
New Talisman Gold Mines (NTL) / FY26
Operating cash outflow widened to NZ$2.0m, showing a cash-hungry gold explorer behind a distorted profit swing.
2 July 2026
Third Age Health Services (TAH) / FY26
Aged-care consolidation lifted earnings and revenue mix, but a halved dividend and weaker cash conversion signal a clear reinvestment pivot.
29 May 2026
Iperion (IPR) / FY26
Operating losses keep absorbing the balance sheet; total equity fell 84.5% to NZ$0.1m while the Pathoglaze licence still produces no revenue.
29 May 2026
Burger Fuel Group (BFG) / FY26
A one-off store-sale gain and lower legal costs flattered all earnings lines, so the durability of record-high margins is the key question for FY27.
29 May 2026
ArborGen Holdings (ARB) / FY26
Revenue grew 7.9% to a five-year high, but margin compression and rising leverage leave cash generation well below ArborGen's historical baseline.
29 May 2026
Truscreen Group (TRU) / FY26
A 140bps gross margin lift is real, but a $1.0m receivables build and ongoing $2.5m operating cash burn keep the runway question open.
29 May 2026
ikeGPS Group (IKE) / FY26
Platform subscription revenue grew ~33% and gross margin expanded 1,099bps, but operating cash flow swung to NZ$-3.4m and inventory days jumped
29 May 2026
Green Cross Health (GXH) / FY26
The earnings step-up was concentrated in the smaller Medical services segment while operating cash flow grew only 3.7% and free cash flow fell.
29 May 2026
Cooks Coffee Company (CCC) / FY26
EBITDA stayed essentially flat at NZ$1.3m while cash dropped 58.2% to NZ$1.1m on debt repayment and elevated working-capital absorption.
29 May 2026
Promisia Healthcare (PHL) / FY26
Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls to 5.8x.
28 May 2026
Methodology
This page uses recently published briefings and shows the latest ten result briefings by release chronology. The takeaway is drawn from the standard Annolyse briefing summary fields.
Get new Annolyse briefings by email as reporting-season updates land.